CambiNet works with venture capitalists to assess potential biotech investments and to help reduce investment risks associated with underperforming management or inefficient business processes.

Investment assessment

Prior to committing to an investment in the biotech sector, it is invaluable to have a full assessment of the investment potential and risks. CambiNet are able to assess:

• All associated business risks
• Regulatory and legislative compliance obligations
• The most appropriate best business practice standards for the business
• The training requirements of key individuals to deliver against business objectives.

What the assessment will tell you

Following our assessment of investment potential and risks, you will better understand the strengths and weaknesses of the business plan, management team, and product. You will also know whether the product or service is capable of realising significant gross profit margin to protect the proposed level of biotech investment.

Implementing positive change

CambiNet works on an ongoing basis with biotech companies to implement remediation plans and to measure and report progress in achieving business and managing investment risk. We also ensure ongoing maintenance of regulatory and legislative compliance obligations.

Find out more

biotech investments

business process improvement

process improvement training

Contact us for a free consultation

T:+44(0)1223 858350

enquiries@cambinet.com

www.cambinet.com

CambiNet Limited
St Johns Innovation Centre
Cowley Road
Cambridge
CB4 OWS

Registration No: 5647171

A member of The Cambridge Web